Success Story: Thanks to Premium Processing, an Indian Director of Business and Research Strategy got his EB1-B Petition Approved in the Field of Biochemistry in just 8 Days!

Posted by wegreened on September 20, 2023 in EB1 Green Card, Chemistry (Organic Chemistry, Biochemistry, Biochemical Engineering, Electrochemical Engineering, Physical Chemistry, Macromolecular Engineering, Polymer Chemistry, Chemical Engineering)

Client’s Testimonial:

“Thank you for your help!”

On April 7^th, 2023, we received another EB-1B (Outstanding Professors and Researchers) approval for a Director of Business and Research Strategy in the field of Biochemistry (Approval Notice).

General Field: Biochemistry

Position at the Time of Case Filing: Director of Business and Research Strategy

Country of Origin: India

State of Residence at the Time of Filing: California

Approval Notice Date: April 7^th, 2023

Processing Time: 8 days (Premium Processing Requested)

Case Summary:

“[Client’s] past record of success all but guarantees his ability to continue making groundbreaking contributions to biochemistry and physiology of muscle. I cannot overstate the value of [client’s] research and fully believe he is an indispensable member of the field.”

The above snippet is extracted from one of the five recommendation letters our client, a director of business and research strategy, achieved in his field of biochemistry. He approached NAILG to help him acquire his EB-1B (Outstanding Professors and Researchers) petition approval. We made sure that he received the best legal assistance for the same.

Although to be qualified for the EB1-B category, the petition must:

Show international recognition as being outstanding in a specific academic area.
The foreign national must have at least 3 years of experience in teaching or researching in the academic area.
While no labor certification is required, there must be an offer of ongoing employment from the sponsoring employer.

Therefore, after reviewing his credentials, we found that our client has gathered an awe-inspiring record of success:

He received his Ph.D. in physiology.
His research has resulted in 16 peer-reviewed articles, 1 preprint article, and 2 book chapters.
His publications have been cited 1,035 times according to Google Scholar, thereby signifying that these publications are widely acknowledged and counted upon in the field of his expertise.
He has conducted at least 25 reviews.

Additionally, our client’s research addresses some of our nation’s most pressing issues in understanding how to develop treatments for heart diseases like HCM, as well as other diseases like cancer and parasitic infections. His strong background in molecular biology and biophysics has allowed his research to be particularly original, with applications such as drug development and disease containment. He is particularly well-known for his contributions to demonstrating the mechanism of action of Mavacamten (trade name Camzyos) in treating HCM.

We are therefore confident that he is more than capable of furthering his knowledge base in the chosen field and continuing his work in the United States of America. Thus, he received his EB-1B approval in just 8 days (thanks to premium processing) and has I-140 NIW in preparation.

We would like to thank him for trusting us during the whole immigration process and would like to send our best wishes for his future endeavors.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%